CIK 0001644963 · Non-accelerated filer<br>Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474113275
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- 4 Grant or award 10% owner acquired 111,209 shares (grant or award)
- 4 Grant or award 10% owner acquired 33,724 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 23 shares at $2.00 ($46)
- 4 Open-market sale Director sold 61 shares at $2.24 ($137)
- 4 Open-market buy Director bought 500 shares at an average $2.50 ($1,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 170,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Interim PFO and COO acquired 65,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award 10% owner acquired 413,507 shares (grant or award)
- 4 Grant or award 10% owner acquired 2,101,496 shares (grant or award)
- 4 Open-market sale 10% owner sold 617,000 shares at an average $0.14 ($86,560)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 348,675 shares at $0.72 ($251,046)
- 4 Open-market buy 10% owner bought 418,410 shares at $0.72 ($301,255)
- 4 Derivatives Options or other derivatives
Page 1 of 5 · 96 filings